HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Vyome Holdings, Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$1.84−0.03 (-1.60%)

Close on Oct 19, 2026

Market cap: $12.91M
P/E (TTM): –
Dividend yield: –

Community

Notes and questions about Vyome from other investors

No posts about HIND yet

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Vyome's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-201 reverse split on Mar 18, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HIND.

Company	Revenue	Growth
HIND	$129.72K	-67.1%
LSTA	$100.00K	-90.7%
SNGX	–	–
IXHL	–	–
KZIA	–	–
KPRX	–	–

Company

Next earnings (est.): Nov 18, 2026, during market hours
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 18
Held by institutions: 2.0%
Auditor: Kreit and Chiu CPA LLP
SEC CIK: 1427570

Advertisement
300 × 250